Evidence map›Paper›PMID 34698226›Full record

ArticleInfectious disease reports2021

Autochthonous North American Leprosy: A Second Case in Canada.

Prenilla Naidu, Rahul Sharma, Jamil N Kanji, Vilma Marks, Arienne King

Open access · goldAbstract readCase Reports
In one paragraph

Article in Infectious disease reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Hansen's disease (leprosy) in Japan, 1947-2020: an epidemiologic study during the declining phase to elimination.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Prenilla NaiduPublic Health Laboratory, Alberta Precision Laboratories, University of Alberta Hospital, Edmonton, AB T6G 2J2, Canada.ORCID 0000-0002-7028-098X
Rahul SharmaU.S. Department of Health and Human Services, Health Resources and Services, Health Systems Bureau, National Hansen's Disease Program Laboratory, Baton Rouge, LA 70809, USA.
Jamil N KanjiPublic Health Laboratory, Alberta Precision Laboratories, University of Alberta Hospital, Edmonton, AB T6G 2J2, Canada.
Vilma MarksU.S. Department of Health and Human Services, Health Resources and Services, Health Systems Bureau, National Hansen's Disease Program Laboratory, Baton Rouge, LA 70809, USA.
Arienne KingDivision of Infectious Diseases, Department of Medicine, Faculty of Medicine & Dentistry, University of Alberta, Edmonton, AB T6G 2R3, Canada.
University of Alberta · CABrioBiotech (United States) · USNational Hansen's Disease Program · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autochthonous leprosy was reported in the Southern USA in 2011 and has comprised an average of 34% of new cases from 2015 to 2020 in that country. We report a similar case in a patient from Western Canada. A 50-year old male patient presented with a four-year history of a chronic rash. Pathology stains revealed acid-fast bacilli prompting specialist referral. Examination was suspicious for leprosy, which was confirmed on slit skin smears and molecular testing. The patient responded well to treatment. Genotypic testing mapped the organism to the 3I-2 SNP type, which is of European origin and is the type found in implicated armadillo species in North America.

Indexed as

autochthonous leprosyHansen’s diseaseleprosyleprosy genotypingleprosy in North AmericaMycobacterium leprae

Identifiers

PMID34698226
PMCPMC8544447
OpenAlexW3206477858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.